Genetic variations in IREB2 have been associated with increased Alzheimers disease risk, underscoring its role in AD pathogenesis (203)
How FAK Promotes Tumor Progression FAK and paxillin represent well-characterized players in cancer development
What they can help with, when properly prescribed and monitored: Reducing appetite and food noise Meaningful fat loss, including visceral fat reduction Better glucose control and insulin sensitivity Improved cardiometabolic markers in many patients Supporting adherence to nutrition changes by lowering cravings Realistic limitations: They do not build muscle by themselves They can reduce appetite too much, leading to low protein intake if not planned Stopping can lead to regain if lifestyle and strength training are not in place Common side effects and considerations: Nausea, constipation, reflux, diarrhea Gallbladder issues can occur in some cases Rare but serious risks exist, so screening matters Dose and titration are not optional details, they are the whole game If your longevity plan includes fat loss, preserving lean mass, and reducing metabolic strain, this category has the strongest human outcome data right now
SDB, sleep disordered breathing
Preserving or building muscle during a calorie deficit matters for metabolic health, physical function, and long-term weight maintenance
Initial improvements may be observed within 24 weeks, while noticeable or sustained recovery often requires 36 months under medical supervision
